Hikma Pharmaceutical | Spese Operative



Operating Expenses Cambiamento Data
Almirall EUR 195.38M 68.92M 2024-06
argenx SE USD 635.37M 62.66M 2024-12
AstraZeneca USD 9.91B 2.94B 2025-03
Autolus Therapeutics Ltd 75.89M 8.24M 2024-12
Bayer EUR 8.2B 5.59B 2024-12
Fresenius EUR 5.16B 287M 2024-12
Galapagos EUR 233.68M 95.46M 2025-03
Genmab DKK 4.25B 812M 2024-12
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
GRIFOLS EUR 1.6B 128.03M 2024-12
Hikma Pharmaceutical USD 1.24B 87M 2024-06
Lonza CHF 2.52B 776M 2024-06
Merck EUR 4.22B 52M 2024-12
Orion EUR 276.7M 65M 2025-03
Recordati EUR 394.73M 34.25M 2024-09
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
UCB EUR 1.23B 1.31B 2024-06



Hikma Pharmaceutical Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.